Alistair Miller

734 total citations
33 papers, 533 citations indexed

About

Alistair Miller is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Alistair Miller has authored 33 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 5 papers in Physiology. Recurrent topics in Alistair Miller's work include Lung Cancer Treatments and Mutations (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Alistair Miller is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Alistair Miller collaborates with scholars based in Australia, Switzerland and United States. Alistair Miller's co-authors include Brendan J. Jenkins, Saleela M. Ruwanpura, Louise McLeod, Walter Ferlin, Sultan Alhayyani, Philip G. Bardin, Stefan Rose‐John, Prudence A. Russell, D. Neil Watkins and Gary P. Anderson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer Research and Oncogene.

In The Last Decade

Alistair Miller

31 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Miller Australia 13 194 138 134 110 92 33 533
Michaela Brown United Kingdom 12 117 0.6× 107 0.8× 94 0.7× 104 0.9× 80 0.9× 21 634
Emirena Garrafa Italy 15 64 0.3× 197 1.4× 142 1.1× 90 0.8× 82 0.9× 34 669
Or Kalchiem‐Dekel United States 13 373 1.9× 40 0.3× 58 0.4× 144 1.3× 69 0.8× 43 592
Cláudio Galvão de Castro Brazil 13 220 1.1× 160 1.2× 77 0.6× 31 0.3× 17 0.2× 43 510
Monique E. Lodewijk Netherlands 13 306 1.6× 37 0.3× 95 0.7× 303 2.8× 167 1.8× 21 621
Christopher Fraser Australia 13 218 1.1× 261 1.9× 79 0.6× 22 0.2× 86 0.9× 33 799
Vibha Dutta India 13 78 0.4× 143 1.0× 55 0.4× 30 0.3× 62 0.7× 47 557
Kruti Patel United States 12 79 0.4× 103 0.7× 53 0.4× 24 0.2× 45 0.5× 52 423
Adlette Inati Lebanon 23 73 0.4× 47 0.3× 105 0.8× 92 0.8× 68 0.7× 84 1.4k
Beatriz González Aguilera Spain 15 52 0.3× 121 0.9× 137 1.0× 18 0.2× 39 0.4× 24 728

Countries citing papers authored by Alistair Miller

Since Specialization
Citations

This map shows the geographic impact of Alistair Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Miller more than expected).

Fields of papers citing papers by Alistair Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Miller. The network helps show where Alistair Miller may publish in the future.

Co-authorship network of co-authors of Alistair Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Miller. A scholar is included among the top collaborators of Alistair Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Miller. Alistair Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Alistair, et al.. (2025). Granulomatous Interstitial Lung Disease: A Case Series in an Australian Tertiary Centre. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6075–A6075.
2.
Allard, N. F., Alistair Miller, Mark Morgan, & Samantha Chakraborty. (2022). Post–COVID-19 syndrome/condition or long COVID: Persistent illness after acute SARS CoV-2 infection. Australian Journal of General Practice. 51(12). 952–957. 5 indexed citations
3.
Singh, Kasha P., Steven Y. C. Tong, Louis Irving, et al.. (2022). COVID‐19 pandemic 2020: a tertiary Melbourne hospital's experience. Internal Medicine Journal. 52(7). 1129–1134. 1 indexed citations
4.
Mooney, Christine H., et al.. (2021). Bereaved families’ experiences of end-of-life decision making for general medicine patients. BMJ Supportive & Palliative Care. 14(e1). e912–e918. 4 indexed citations
5.
Neeson, Paul J., Thomas John, Stephen Barnett, et al.. (2021). A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer. Translational Lung Cancer Research. 10(6). 2766–2778. 10 indexed citations
6.
Miller, Alistair & Renée Manser. (2021). The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review. Translational Lung Cancer Research. 10(6). 2752–2765. 6 indexed citations
7.
8.
Miller, Alistair, et al.. (2019). Lung nodules are reliably detectable on ultra-low-dose CT utilising model-based iterative reconstruction with radiation equivalent to plain radiography. Clinical Radiology. 74(5). 409.e17–409.e22. 14 indexed citations
9.
Barnett, Stephen, Douglas Johnson, Simon Knight, et al.. (2018). Outcomes following resection of non‐small cell lung cancer in octogenarians. ANZ Journal of Surgery. 88(12). 1322–1327. 12 indexed citations
10.
Jamsai, Duangporn, D. Neil Watkins, Anne E. O’Connor, et al.. (2017). In vivo evidence that RBM5 is a tumour suppressor in the lung. Scientific Reports. 7(1). 16323–16323. 22 indexed citations
11.
Robertson, James, et al.. (2017). Incidental Pulmonary Nodules Are Common on CT Coronary Angiogram and Have a Significant Cost Impact. Heart Lung and Circulation. 28(2). 295–301. 17 indexed citations
12.
McLeod, Louise, Sultan Alhayyani, Alistair Miller, et al.. (2016). IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. Cancer Research. 76(4). 866–876. 95 indexed citations
13.
Miller, Alistair, Louise McLeod, Sultan Alhayyani, et al.. (2016). Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma. Oncogene. 36(21). 3059–3066. 74 indexed citations
14.
Davis, Rick, et al.. (2016). A case of massive aortic mural thrombus in the absence of atherosclerotic or aneurysmal disease. IJC Heart & Vasculature. 12. 82–84. 5 indexed citations
15.
Miller, Alistair, et al.. (2014). Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis. Oncogene. 34(12). 1510–1519. 15 indexed citations
16.
Ruwanpura, Saleela M., Louise McLeod, Alistair Miller, et al.. (2011). Interleukin-6 Promotes Pulmonary Emphysema Associated with Apoptosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 45(4). 720–730. 62 indexed citations
17.
Miller, Alistair, et al.. (2009). Dual‐energy X‐ray absorptiometry is the method of choice to assess body composition in COPD. Respirology. 14(3). 411–418. 22 indexed citations
18.
Jones, Jessica, Louise McLeod, Alistair Miller, et al.. (2009). Deregulated Activation of Cytokine Signaling Pathways in Emphysema.. A2221–A2221. 1 indexed citations
19.
Tucker, Adam, et al.. (2006). Continuing Medical Education: A Needs Analysis of Anaesthetists. Anaesthesia and Intensive Care. 34(6). 765–769. 4 indexed citations
20.
Griffin, George E., Alistair Miller, P A Batman, et al.. (1988). Damage to jejunal intrinsic autonomic nerves in HIV infection. AIDS. 2(5). 379–382. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaela Brown Breakdown of academic impact, for papers by Emirena Garrafa Breakdown of academic impact, for papers by Or Kalchiem‐Dekel Breakdown of academic impact, for papers by Cláudio Galvão de Castro Breakdown of academic impact, for papers by Monique E. Lodewijk Breakdown of academic impact, for papers by Christopher Fraser Breakdown of academic impact, for papers by Vibha Dutta Breakdown of academic impact, for papers by Kruti Patel Breakdown of academic impact, for papers by Adlette Inati Breakdown of academic impact, for papers by Beatriz González Aguilera
Rankless by CCL
2026